Perfect Optronics Limited provided unaudited consolidated group earnings guidance for the year ended 31 December 2022 (FY2022). For the year, the group expects to record a turnaround of its results from loss to profit making by recording a consolidated profit attributable to equity holders of the Company of not more than HKD 5 million, as compared to a consolidated loss attributable to equity holders of the Company of approximately HKD 43,857,000 for the year ended 31 December 2021 (FY2021). The abovementioned consolidated profit expected to be recorded for FY2022 was primarily attributable to a significant increase in the profit generated from the Group's sales of health-related products (including personal hygiene and disinfectant products, rapid antigen test kits for COVID-19) during FY2022 as compared to FY2021; and the expected decrease in fair value loss on the Group's financial asset at fair value through profit or loss (FVTPL) in respect of its investment in Mobvoi Inc. for FY2022 as compared to the fair value loss on the Group's financial asset at FVTPL for FY2021.

The Board also updated the Shareholders and potential investors that the Group may record a significant decrease in its revenue for the two months ended 28 February 2023 as compared to the corresponding period in 2022, mainly due to the significant decrease in sales of the Group's health-related products (which could be related to Hong Kong's recent returning from having anti-epidemic measures back to normalcy since January 2023) and display products. Without taking into account other factors, the Group's financial results for the three months ending 31 March 2023 are expected to be adversely affected significantly by such business performances.